跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RY ILEX - NPRA Drug Approval Details
Approvals
/
NPRA
/
RY ILEX
Approved
STANDARD
RY ILEX
ORIENT LABORATORIES SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
6164da3ca092f51a
Company
ORIENT LABORATORIES SDN. BHD.
Type
Standard
Approval Details
Approval Id
6164da3ca092f51a
Drug Approval Npra Name
RY ILEX
Product Name
RY ILEX
Registration Number
MAL20031882T
Holder Company Name
ORIENT LABORATORIES SDN. BHD.
Holder Address
NO. 37, JALAN PS 3 TAMAN INDUSTRI PRIMA SELAYANG 68100 BATU CAVES MALAYSIA
Holder Phone
03-61388306
Manufacturer Company Name
ORIENT LABORATORIES SDN. BHD.
Manufacturer Address
NO. 37, JALAN PS 3 TAMAN INDUSTRI PRIMA SELAYANG 68100 BATU CAVES MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL20031882T
Version
1751614557
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
6164da3ca092f51a
Type
Standard
Source
Official Source
Back to NPRA Approvals